Results 191 to 200 of about 34,166 (308)

An interpretable machine learning model for predicting metabolic dysfunction‐associated steatotic liver disease in patients with type 2 diabetes

Diabetes, Obesity and Metabolism, EarlyView.
Abstract Aim Patients with type 2 diabetes mellitus (T2DM) exhibit an elevated prevalence of metabolic dysfunction‐associated steatotic liver disease (MASLD) and are at greater risk of liver‐related adverse events. Existing non‐invasive tools show limited diagnostic performance in this population.
Zhuolin Zhou, Nan Gao, Jiaojiao Liu, Xuerong Ma, Zhijuan Ge, Cheng Ji   +5 more
wiley   +1 more source

Effectiveness of Acupuncture for Diabetic Nephropathy: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. [PDF]

Iran J Public Health
Wu C, Li Y, Piao C, Wu J.
europepmc   +1 more source

Mast cells and type VIII collagen in human diabetic nephropathy

, 1996
Beate M. Rüger, Qurratulain Hasan, Nicholas S. Greenhill, Paul F. Davis, P. R. Dunbar, T J Neale   +5 more
openalex   +1 more source

The 5 ′-end polymorphism of the aldose reductase gene is not associated with diabetic nephropathy in Caucasian Type I diabetic patients [PDF]

, 1999
Not Available Not Available
openalex   +1 more source

Efficacy and safety of once‐weekly basal insulin therapy in people with type 1 diabetes: A systematic review and meta‐analysis

Diabetes, Obesity and Metabolism, EarlyView.
Abstract Aims Once‐weekly basal insulins may offer similar or superior HbA1c reduction compared to once‐daily analogues in people with type 1 or type 2 diabetes. However, concerns about hypoglycaemia persist in individuals on multiple daily injections. This meta‐analysis (PROSPERO CRD42024606874) aimed to evaluate the efficacy and safety of once‐weekly
Ludovico Di Gioia, Sergio Di Molfetta, Irene Caruso, Mariangela Caporusso, Gian Pio Sorice, Angelo Cignarelli, Annalisa Natalicchio, Sebastio Perrini, Luigi Laviola, Francesco Giorgino   +9 more
wiley   +1 more source

Comprehensive bioinformatics and <i>in vivo</i> validation reveal key molecular drivers of diabetic nephropathy progression. [PDF]

Front Endocrinol (Lausanne)
Yang Y, He X, Liu W, Mu L, Wang S.
europepmc   +1 more source

Production of Superoxide and Nitric Oxide by Granulocytes in Non‐Insulin‐Dependent Diabetic Patients With and Without Diabetic Nephropathy [PDF]

, 1999
Kornelia Kędziora‐Kornatowska
openalex   +1 more source

Addressing unmet needs for chronic kidney disease treatment in type 1 diabetes: A review

Diabetes, Obesity and Metabolism, EarlyView.
Abstract Chronic kidney disease (CKD) is a serious complication occurring in nearly one of three people with type 1 diabetes (T1D). Major therapeutic advances have been made in the management of CKD for people with type 2 diabetes (T2D), thereby improving their kidney, cardiovascular, and survival outcomes.
Katherine R. Tuttle, Linong Ji, Chantal Mathieu, Jonathan Rosen   +3 more
wiley   +1 more source

Effect of Renal Denervation on Early and Late Stages of Diabetic Nephropathy. [PDF]

FASEB J
Xu B, Lowe M, Levchenko V, Morales MN, Klemens CA, Banek CT, Staruschenko A.   +6 more
europepmc   +1 more source

Predictors of the progression of renal insufficiency in patients with insulin-dependent diabetes and overt diabetic nephropathy

, 1996
Julia A. Breyer, Raymond P. Bain, Joni K. Evans, N. Stanley Nahman, Edmund J. Lewis, Melisa Cooper, Janet B. McGill, Tomás Berl, the Collaborative Study Group   +8 more
openalex   +1 more source